Search
for
Sort by
Research 61–90 of 139
- Advances in dermatology research: A comprehensive literature review
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Ritlecitinib in severe alopecia areata: a profile of its use
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- 609 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates female telogen effluvium: Randomized, double-blinded, placebo-controlled clinical trial
- 606 The role of diet in patients with autoimmune blistering disease: A survey of the International Pemphigus and Pemphigoid Foundation
- Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Drug-induced alopecia after dupilumab therapy
- Dupilumab side effect in a patient with atopic dermatitis: a case report study
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- Biologics in the management of childhood atopic dermatitis
- Bletilla striata polysaccharide-based dissolving microneedle patch integrated with nanoparticles for promoting hair regrowth
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Case Report: Omalizumab-associated hair loss: a case of eyebrow alopecia areata, literature review and FAERS database analysis
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- The JAK/STAT signaling pathway: from bench to clinic
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Alopecia Areata: An Updated Review for 2023
- Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Oral isotretinoin for acne
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata